KellyH, KeimK, McWilliamsB. Comparison of two methods of delivering continuously nebulized albuterol. Ann Pharmacother, 2003; 37(1):23–26.
2.
PapoMC, FrankJ, ThompsonAE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med, 1993; 21(10):1479–1486.
3.
KhineH, FuchsSM, SavilleAL. Continuous vs intermittent nebulized albuterol for emergency management of asthma. Acad Emerg Med, 1996; 3(11):1019–1024.
4.
CamargoCAJr, SpoonerCH, RoweBH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev, 2003;(4):CD001115.
5.
FinkJ, DhandR. Bronchodilator resuscitation in the emergency department, part 1: device selection. Respir Care, 1999; 44(10):1353–1374.
6.
ReisnerC, KotchA, DworkinG. Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized prospective study. Ann Allergy Asthma Immunol, 1995; 75(1):41–47.
7.
BerlinskiA, WillisJR, LeisenringT. In-vitro comparison of 4 large-volume nebulizers in 8 hours of continuous nebulization. Respir Care, 2010; 55(12):1671–1679.
RauJL, AriA, RestrepoRD. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir Care, 2004; 49(2):174–179.
10.
SangwanS, CondosR, SmaldoneG. Lung deposition and respirable mass during wet nebulization. J Aerosol Med, 2003; 16(4):379–386.
11.
SabatoK, WardP, HawkW, GildengorinV, AsselinJM. Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department. Respir Care, 2011; 56(6):761–770.
12.
BentonG, ThomasRC, NickersonBG, McQuittyJC, OkikawaJ. Experience with a metered-dose inhaler with a spacer in the pediatric emergency department. Am J Dis Child, 1989; 143(6):678–681.
13.
Esposito-FestenJE, AtesB, van VlietFJ, VerbraakAF, de JongsteJC, TiddensHA. Effect of a facemask leak on aerosol delivery from a pMDI-spacer system. J Aerosol Med, 2004; 17(1):1–6.
14.
SmaldoneGC, SangwanS, ShahA. Facemask design, facial deposition, and delivered dose of nebulized aerosols. J Aerosol Med, 2007; 20(Suppl 1):S66–S75.
15.
RauJL, SmaldoneGC. The interface between the device and the patient: masks, mouthpieces, and “others”. Introduction. J Aerosol Med, 2007; 20(Suppl 1):S1–S2.
16.
JanssensH, TiddensH. Aerosol therapy: the special needs of young children. Pediatr Respir Rev, 2006; 7(Suppl 1):S83–S85.
17.
JanssensHM, TiddensHA. Facemasks and aerosol delivery by metered dose inhaler-valved holding chamber in young children: a tight seal makes the difference. J Aerosol Med, 2007; 20(Suppl 1):S59–S63.
18.
ErzingerS, SchueeppKG, Brooks-WildhaberJ, DevadasonSG, WildhaberJH. Facemasks and aerosol delivery in vivo. J Aerosol Med, 2007; 20(Suppl 1):S78–S83.
19.
RestrepoRD, DicksonSK, RauJL, GardenhireDS. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing. Respir Care, 2006; 51(1):56–61.
20.
LinHL, RestrepoRD, GardenhireDS, RauJL. Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model. Respir Care, 2007; 52(8):1021–1026.
21.
RubinBK. Bye-bye, blow-by (editorial). Respir Care, 2007; 52(8):981.
22.
EverardML. Inhaler devices in infants and children: challenges and solutions. J Aerosol Med, 2004; 17(2):186–195.
23.
EverardML. Aerosol delivery to children. Pediatr Ann, 2006; 35(9):630–636.
24.
JanssensH, van der WielE, VerbraakA, de JongsteJ, MerkusP, TiddensH. Aerosol therapy and the fighting toddler: is administration during sleep an alternative?. J Aerosol Med, 2003; 16(4):395–400.
25.
AriA, HarwoodR, SheardM, DaileyP, FinkJB. In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatr Pulmonol, 2011;[Epub ahead of print]. doi: 10.1002/ppul.21421.
26.
BhashyamAR, WolfMT, MarcinkowskiAL, SavilleA, ThomasK, CarcilloJA, CorcoranTE. Aerosol delivery through nasal cannulas: an in vitro study. J Aerosol Med Pulm Drug Deliv, 2008; 21(2):181–188.
